Home Page
News Lines
Classifieds
Real Estate MLS
Profiles
Arcade
Business Directory
Hotels
Advertise
Long Island New York
Google Web Site
 
 

PHARMACEUTICAL NEWS LINES

Advertisement



Warrant: Drug in Jackson case came from Vegas firm (AP) AP - Court documents show police linked a drug blamed in Michael Jackson's death to the pop singer's personal physician who bought it at a Las Vegas pharmacy.




BioCryst prices stock offering at $9.75 per share (AP) AP - Flu drug developer BioCryst Pharmaceuticals Inc. priced its 5 million common stock share offering at $9.75 per share.


FDA issues warnings to Web sites over drug sales (AP) AP - The Food and Drug Administration said Thursday it issued 22 warning letters to Web site operators over alleged illegal sales of unapproved or misbranded drugs.


Momenta rises on upgrade ahead of Lovenox ruling (AP) AP - Shares of Momenta Pharmaceuticals Inc. rose Thursday after an analyst upgraded the stock, saying Momenta will soon receive marketing approval for its version of the anti-clotting drug Lovenox.


Ligand receives $2 million from Merck partnership (AP) AP - Ligand Pharmaceuticals Inc. said Thursday it received a $2 million milestone payment from Merck & Co. as part of a research collaboration.


PPD buying BioDuro in China expansion (AP) AP - Drug development contractor Pharmaceutical Product Development Inc. said Wednesday it will buy BioDuro LLC in a move to expand capabilities in China.


Delcath Systems share offering raises $32 million (AP) AP - Delcath Systems Inc., a developer of a cancer-drug delivery device, said Wednesday it raised $32.4 million in net proceeds from a public stock offering.


Ex-pharma executive runs as Dem for Kan. governor (AP) AP - A former pharmaceutical company executive who returned to Kansas this year announced Tuesday that he's running for governor, giving Democrats a declared candidate.


Vaccines on horizon for AIDS, Alzheimer's, herpes (AP) AP - Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.


Poniard rebounds on picoplatin colon cancer data (AP) AP - A day after Poniard Pharmaceuticals Inc. said its drug candidate picoplatin failed to improve survival for patients with lung cancer, the company reported positive data on the drug as a treatment for colorectal cancer.


You can save this news page by submitting it to your favorite sites: Social Bookmark News

All News Lines - Local and World Wide, Updated Hourly

RSS news lines are HTML instructions and not actual copy. They are displayed here through the doctrine of fair use in the U.S. Copyright Act which allows us to show snippets and links to news and other materials. The fair use doctrine protects limited uses of content, such as indexing to make it easier to find. This allows us to send visitors to breaking news web sites. If your news appears here against your wishes please contact us for removal, disable your RSS feeds or implement simple technical standards such as robots.txt or metatags to prevent search engines (Yahoo and MSN) from feeding us your snippets and links.

 

 
   By using this site you agree to our Terms of Service and Privacy Policy. If you do not agree, please exit the service.
   Copyright © 2002 - 2009 Long Island Exchange ®. All rights reserved. Internet Marketing by Searchen Networks ® Inc.